Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Q4 2023 13F Portfolio Holders as of 12/31/2023

Type / Class
Equity / COM SHS
Number of holders
85
Total Shares
130M
Shares change
-1.11M
Total reported value, excl. options
$230M
Value change
-$12.3M
Put/Call ratio
0.3
Number of buys
56
Number of sells
-18
Price
$1.77
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.